125 related articles for article (PubMed ID: 32162837)
1. Shape Similarity by Fractal Dimensionality: An Application in the de novo Design of (-)-Englerin A Mimetics.
Friedrich L; Byrne R; Treder A; Singh I; Bauer C; Gudermann T; Mederos Y Schnitzler M; Storch U; Schneider G
ChemMedChem; 2020 Apr; 15(7):566-570. PubMed ID: 32162837
[TBL] [Abstract][Full Text] [Related]
2. Englerin A Agonizes the TRPC4/C5 Cation Channels to Inhibit Tumor Cell Line Proliferation.
Carson C; Raman P; Tullai J; Xu L; Henault M; Thomas E; Yeola S; Lao J; McPate M; Verkuyl JM; Marsh G; Sarber J; Amaral A; Bailey S; Lubicka D; Pham H; Miranda N; Ding J; Tang HM; Ju H; Tranter P; Ji N; Krastel P; Jain RK; Schumacher AM; Loureiro JJ; George E; Berellini G; Ross NT; Bushell SM; Erdemli G; Solomon JM
PLoS One; 2015; 10(6):e0127498. PubMed ID: 26098886
[TBL] [Abstract][Full Text] [Related]
3. (-)-Englerin A is a potent and selective activator of TRPC4 and TRPC5 calcium channels.
Akbulut Y; Gaunt HJ; Muraki K; Ludlow MJ; Amer MS; Bruns A; Vasudev NS; Radtke L; Willot M; Hahn S; Seitz T; Ziegler S; Christmann M; Beech DJ; Waldmann H
Angew Chem Int Ed Engl; 2015 Mar; 54(12):3787-91. PubMed ID: 25707820
[TBL] [Abstract][Full Text] [Related]
4. 3-Ylidenephthalides as a new class of transient receptor potential channel TRPA1 and TRPM8 modulators.
Ortar G; Schiano Moriello A; Morera E; Nalli M; Di Marzo V; De Petrocellis L
Bioorg Med Chem Lett; 2013 Oct; 23(20):5614-8. PubMed ID: 23993334
[TBL] [Abstract][Full Text] [Related]
5. Identification of an (-)-englerin A analogue, which antagonizes (-)-englerin A at TRPC1/4/5 channels.
Rubaiy HN; Seitz T; Hahn S; Choidas A; Habenberger P; Klebl B; Dinkel K; Nussbaumer P; Waldmann H; Christmann M; Beech DJ
Br J Pharmacol; 2018 Mar; 175(5):830-839. PubMed ID: 29247460
[TBL] [Abstract][Full Text] [Related]
6. Triple-negative breast cancer cell line sensitivity to englerin A identifies a new, targetable subtype.
Grant CV; Carver CM; Hastings SD; Ramachandran K; Muniswamy M; Risinger AL; Beutler JA; Mooberry SL
Breast Cancer Res Treat; 2019 Sep; 177(2):345-355. PubMed ID: 31230251
[TBL] [Abstract][Full Text] [Related]
7. Na
Muraki K; Ohnishi K; Takezawa A; Suzuki H; Hatano N; Muraki Y; Hamzah N; Foster R; Waldmann H; Nussbaumer P; Christmann M; Bon RS; Beech DJ
Sci Rep; 2017 Dec; 7(1):16988. PubMed ID: 29209034
[TBL] [Abstract][Full Text] [Related]
8. (-)-Englerin A-evoked Cytotoxicity Is Mediated by Na+ Influx and Counteracted by Na+/K+-ATPase.
Ludlow MJ; Gaunt HJ; Rubaiy HN; Musialowski KE; Blythe NM; Vasudev NS; Muraki K; Beech DJ
J Biol Chem; 2017 Jan; 292(2):723-731. PubMed ID: 27875305
[TBL] [Abstract][Full Text] [Related]
9. Pico145 - powerful new tool for TRPC1/4/5 channels.
Rubaiy HN; Ludlow MJ; Bon RS; Beech DJ
Channels (Austin); 2017 Sep; 11(5):362-364. PubMed ID: 28399685
[No Abstract] [Full Text] [Related]
10. Leucettamols, bifunctionalized marine sphingoids, act as modulators of TRPA1 and TRPM8 channels.
Chianese G; Fattorusso E; Putra MY; Calcinai B; Bavestrello G; Moriello AS; De Petrocellis L; Di Marzo V; Taglialatela-Scafati O
Mar Drugs; 2012 Nov; 10(11):2435-47. PubMed ID: 23203269
[TBL] [Abstract][Full Text] [Related]
11. Unveiling (-)-Englerin A as a Modulator of L-Type Calcium Channels.
Rodrigues T; Sieglitz F; Somovilla VJ; Cal PM; Galione A; Corzana F; Bernardes GJ
Angew Chem Int Ed Engl; 2016 Sep; 55(37):11077-81. PubMed ID: 27391219
[TBL] [Abstract][Full Text] [Related]
12. Identification and optimization of 2-aminobenzimidazole derivatives as novel inhibitors of TRPC4 and TRPC5 channels.
Zhu Y; Lu Y; Qu C; Miller M; Tian J; Thakur DP; Zhu J; Deng Z; Hu X; Wu M; McManus OB; Li M; Hong X; Zhu MX; Luo HR
Br J Pharmacol; 2015 Jul; 172(14):3495-509. PubMed ID: 25816897
[TBL] [Abstract][Full Text] [Related]
13. Total synthesis of englerin A.
Nicolaou KC; Kang Q; Ng SY; Chen DY
J Am Chem Soc; 2010 Jun; 132(23):8219-22. PubMed ID: 20496885
[TBL] [Abstract][Full Text] [Related]
14. Total synthesis and biological evaluation of (-)-9-deoxy-englerin A.
Ushakov DB; Navickas V; Ströbele M; Maichle-Mössmer C; Sasse F; Maier ME
Org Lett; 2011 Apr; 13(8):2090-3. PubMed ID: 21413694
[TBL] [Abstract][Full Text] [Related]
15. Enantioselective formal synthesis of (-)-englerin A via a Rh-catalyzed [4 + 3] cycloaddition reaction.
Xu J; Caro-Diaz EJ; Theodorakis EA
Org Lett; 2010 Aug; 12(16):3708-11. PubMed ID: 20669919
[TBL] [Abstract][Full Text] [Related]
16. Englerin a selectively induces necrosis in human renal cancer cells.
Sulzmaier FJ; Li Z; Nakashige ML; Fash DM; Chain WJ; Ramos JW
PLoS One; 2012; 7(10):e48032. PubMed ID: 23144724
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological activities of 2,3-dihydroquinazolin-4(1H)-one derivatives as TRPM2 inhibitors.
Zhang H; Liu H; Luo X; Wang Y; Liu Y; Jin H; Liu Z; Yang W; Yu P; Zhang L; Zhang L
Eur J Med Chem; 2018 May; 152():235-252. PubMed ID: 29723786
[TBL] [Abstract][Full Text] [Related]
18. A formal synthesis of (-)-englerin A by relay ring closing metathesis and transannular etherification.
Lee J; Parker KA
Org Lett; 2012 Jun; 14(11):2682-5. PubMed ID: 22564056
[TBL] [Abstract][Full Text] [Related]
19. Total synthesis and biological evaluation of (-)-englerin A and B: synthesis of analogues with improved activity profile.
Radtke L; Willot M; Sun H; Ziegler S; Sauerland S; Strohmann C; Fröhlich R; Habenberger P; Waldmann H; Christmann M
Angew Chem Int Ed Engl; 2011 Apr; 50(17):3998-4002. PubMed ID: 21472928
[No Abstract] [Full Text] [Related]
20. Synthesis and Biological Evaluation of New (-)-Englerin Analogues.
López-Suárez L; Riesgo L; Bravo F; Ransom TT; Beutler JA; Echavarren AM
ChemMedChem; 2016 May; 11(9):1003-7. PubMed ID: 27005578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
